Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance

I. Khan, A. Kaempf, S. Raghuwanshi, M. Chesnokov, X. Zhang, Z. Wang, A. Domling, JW. Tyner, C. Camacho, AL. Gartel

. 2023 ; 13 (1) : 128. [pub] 20230822

Language English Country United States

Document type Letter, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc23016525

Grant support
R21 TR003587 NCATS NIH HHS - United States

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016525
003      
CZ-PrNML
005      
20231026105740.0
007      
ta
008      
231013s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41408-023-00898-4 $2 doi
035    __
$a (PubMed)37607920
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Khan, I $u University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA $u Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA $1 https://orcid.org/0000000318557731
245    10
$a Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance / $c I. Khan, A. Kaempf, S. Raghuwanshi, M. Chesnokov, X. Zhang, Z. Wang, A. Domling, JW. Tyner, C. Camacho, AL. Gartel
650    _2
$a lidé $7 D006801
650    12
$a chemorezistence $x genetika $7 D019008
650    _2
$a jaderné proteiny $x genetika $7 D009687
650    12
$a akutní myeloidní leukemie $x farmakoterapie $x genetika $7 D015470
650    _2
$a forkhead box protein M1 $x genetika $7 D000072278
655    _2
$a dopisy $7 D016422
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kaempf, A $u OHSU Knight Cancer Institute, School of Medicine, Portland, OR, USA
700    1_
$a Raghuwanshi, S $u University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA $1 https://orcid.org/0000000335495413
700    1_
$a Chesnokov, M $u Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain $1 https://orcid.org/000000018530692X
700    1_
$a Zhang, X $u University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA
700    1_
$a Wang, Z $u The Czech Advanced Technology and Research Institute (CATRIN) of Palacký University, Olomouc, Czech Republic $u University of Groningen, Groningen, Netherlands
700    1_
$a Domling, A $u The Czech Advanced Technology and Research Institute (CATRIN) of Palacký University, Olomouc, Czech Republic
700    1_
$a Tyner, J W $u OHSU Knight Cancer Institute, School of Medicine, Portland, OR, USA $1 https://orcid.org/0000000221330960
700    1_
$a Camacho, C $u Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA
700    1_
$a Gartel, A L $u University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA. agartel@uic.edu $1 https://orcid.org/0000000309548251
773    0_
$w MED00187996 $t Blood cancer journal $x 2044-5385 $g Roč. 13, č. 1 (2023), s. 128
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37607920 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105734 $b ABA008
999    __
$a ok $b bmc $g 2000191 $s 1202887
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 13 $c 1 $d 128 $e 20230822 $i 2044-5385 $m Blood cancer journal $n Blood Cancer J $x MED00187996
GRA    __
$a R21 TR003587 $p NCATS NIH HHS $2 United States
LZP    __
$a Pubmed-20231013
Back

Find record

Citation metrics

Archiving options